BIO-key receives Nasdaq delisting notice; stock to move to OTC Markets on May 13

BIO KEY INTERNATIONAL INC

• Nasdaq suspends BKYI trading after close May 12 for failing to maintain $1 bid price for 10 consecutive days by May 4 and late Form 10-K.
• Company will request a hearing before a Nasdaq Hearings Panel to appeal delisting; no guarantee of reinstatement.
• Stock to be quoted on OTC Markets under symbol BKYI starting May 13; reverse stock split was effective April 30 but timing fell short.
• CEO states 1H'26 revenue expected to rise 50% to $5M vs $3.3M in 1H'25; targets profitability vs $1.9M net loss in 1H'25.
• Cash position expected to remain in line with year-end 2025 level; company retains listing consultants to expedite Nasdaq return.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.